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Abstract 
A sensitive static headspace gas chromatographic method was developed and 
validated for the determination of residual epichlorohydrin (ECH) in sevelamer 
hydrochloride (SVH) drug substance. This method utilized a Phenomenex 
Zebron ZB-WAX GC column, helium as carrier gas with flame ionization 
detection. The critical experimental parameters, such as, headspace vial 
incubation time and incubation temperature were studied and optimized. The 
method was validated as per United States Pharmacopoeia (USP) and 
International Conference on Harmonization (ICH) guidelines in terms of 
detection limit (DL), quantitation limit (QL), linearity, precision, accuracy, 
specificity and robustness. A linear range from 0.30 to 10 µg/mL was obtained 
with the coefficient of determination (r
2) 0.999. The DL and QL of ECH were 
0.09 µg/mL and 0.30 µg/mL, respectively. The recovery obtained for ECH was 
between 91.7 and 96.6%. Also, the specificity of the method was proved 
through gas chromatography mass spectrometry (GC-MS). This method was 
applied successfully to determine the content of residual ECH in SVH bulk drug.  
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Introduction 
Sevelamer hydrochloride (SVH) drug substance is intended for oral administration in the 
treatment of hyperphosphatemia. SVH acts as a polymeric phosphate binder and it has 
been shown to decrease serum phosphorus concentrations in patients with end-stage 
renal disease. SVH is known chemically as poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-
hydroxypropane hydrochloride) [1]. It is poly(allylamine hydrochloride) crosslinked with 
epichlorohydrin in which forty percent of the amines are protonated. The primary amine 
groups in the structure (Fig. 1.) are derived directly from poly(allylamine hydrochloride), 
and the crosslinking groups consist of two secondary amine groups derived from poly 
(allylamine hydrochloride) and one molecule of epichlorohydrin (ECH). ECH, a bifunctional 
alkylating agent, chemically described as 2-(chloromethyl)oxirane, belongs to a class of 
epoxide compounds that are considered to be “probably carcinogenic to humans” based 
on structure activity relationship [2]. Because of the known carcinogenicity and structural 
alert for genotoxicity, the presence of residual ECH in SVH drug substance must be 
controlled as per European Medicines Agency (EMEA), International Conference on 
Harmonization (ICH) and Food and Drug Administration (FDA) guidelines [3–7]. EMEA 
and FDA guidelines proposed the use of the “threshold of toxicological concern” (TTC) 
concept for the limit of genotoxic / carcinogenic impurities. The TTC refers to a threshold 
exposure level to compounds that do not pose a significant risk for carcinogenicity / 
genotoxicity or other toxic effects; and an exposure level of 1.5 µg per day (TTC)  for 
genotoxic impurity is considered to be associated with an acceptable risk for most 
pharmaceuticals [8,  9]. The concentration limit, in ppm, of genotoxic impurity in drug 
substance, is the ratio of TTC in µg per day to the expected dose of drug substance in 
gram per day. Considering the recommended dose of >2.4g SVH per day, ECH must be 
limited to less than 0.6 µg/g in the drug substance, necessitating the development of 
sensitive, accurate and robust analytical method. 
SVH is not official in any pharmacopoeia; however, few reports are available for ECH 
estimation [10–14]. A GC-FID method was reported for the determination of ECH in 
workplace atmosphere [10]. Trace analysis of ECH in water samples were carried out by 
GC with electron capture detection (ECD) [11]. Also, ECH content in drinking water was 
determined as its sulfonate derivative by ion-chromatography with conductivity detection 
[12]. Lasa et. al published a headspace solid-phase micro extraction (SPME) procedure 
followed by GC analysis for ECH estimation in water [13]. GC-MS method for monitoring 
exposure to ECH by means of quantitative analysis of N-(2,3-dihydroxypropyl)valine 
adduct in hemoglobin was reported [14]. The published methods evaluated ECH, mostly 
on clean sample matrices, such as, water and air. Additionally, these methods [10–14] 
utilized derivatization procedures, adduct analysis, SPME fibers, mass and electro-
chemical detectors. The complexities and limitations of the existing methods and no 
method reported so far, for the determination of ECH in polymeric drug substance (SVH), 
prompted to develop a new method.    Determination of Residual Epichlorohydrin in Sevelamer Hydrochloride by Static Headspace …  837 
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Fig. 1.  Chemical structure of Sevelamer HCl and Epichlorohydrin 
The present investigation was, therefore, initiated with the objective to develop a simple 
and sensitive analytical method for the ECH estimation in SVH drug substance utilizing 
static headspace (HS) GC with FID. An important and critical aspect about SVH is related 
to its solubility. Being a polymeric material, SVH is poorly soluble in most of the commonly 
used organic and aqueous solvents and hence trace level ECH determination in SVH 
sample by a direct and conventional GC method is practically difficult. Thus, the more 
versatile and sensitive static HS-GC method, which is widely used for the estimation of 
organic volatile analytes / residual solvents / reagents in drug compounds was selected. 
The prime advantage of static HS-GC is its application to drug substances / products that 
have low solubility or generate degradation products or thermally decompose on column 
and interfere with the volatile analyte peaks when injected directly [15–17]. Additionally, 
the availability of high level of automation in the static HS instrumentation has extended its 
application potentiality for ECH estimation. Selection of solvents used for extraction, HS 
vial incubation time, incubation temperature and the types of GC column were found to 
play a vital role in the sensitivity and ruggedness of the developed method. The proposed 
HS-GC method with FID has been validated using ICH and USP [18, 19] guidelines as 
references.  
Results and Discussion 
Development of Chromatographic Method 
Because of the poor solubility of SVH, preliminary experiments were conducted to optimize 
the suitable solvent for HS extraction. As SVH is a known hydrophilic polymer having the 
tendency to swell with water [1], utilization of water as solvent was not considered. Several 838 K.  Karthikeyan  et al.:  
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commonly used organic solvents, such as, DMF, DMSO, NMP and DMAc were studied. 
Among the four organic solvents, DMSO was selected because it did not have interference 
peaks and the recovery of ECH was good, whereas, DMF and DMAc had interference 
peaks at the retention of ECH. Problems with poor peak shape and recovery were 
encountered with NMP. Different types of GC columns, such as, DB624 (6% 
cyanopropylphenyl – 94% dimethyl polysiloxane), DB1 (100% dimethyl polysiloxane), and 
ZBWAX (polyethylene glycol) were screened. ZBWAX column yielded a better peak 
efficiency (shape) and acceptable recovery compared to other columns.  
 
Fig. 2.  Effect of variation in (A) incubation temperature and (B) incubation time on the 
area response of ECH 
As a part of method development and robustness evaluation, the following parameters, 
such as, HS incubation temperature, incubation time, flow rate and column oven 
temperature, were studied to achieve high sensitivity and good precision. From the 
investigation, HS incubation time and temperature were found to be very critical. The effect 
of variation in HS incubation time and temperature on the area response of ECH was 
represented graphically in Fig. 2. When the incubation temperature was studied from 80 
°C to 120 °C, there was gradual increase in the area response from 80 °C, reached 
maximum at 100 °C and it was stable up to 105 °C, then, it decreased significantly at 120 
°C. The reason for the lower area at 80 °C could be due to insufficient temperature to bring 
ECH to the gaseous head space and decrease in the area after 105 °C might be due to 
the interaction / reaction of ECH with drug substance. Similarly, when incubation time was 
studied from 5 min to 30 min, peak response of ECH was maximum and almost same   Determination of Residual Epichlorohydrin in Sevelamer Hydrochloride by Static Headspace …  839 
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between 7–15 min but there was a decrease in the area at 30 min. The lower response at 
5 min incubation could be due to inadequate equilibration and sudden decrease in area 
after 15 min might be due to interaction / reaction of ECH with drug substance. Since, ECH 
was used as a cross-linker in the preparation of SVH drug, there is possibility for its 
reaction with drug at higher temperature and prolonged incubation time. Hence, 100 °C 
incubation temperature and 10 min incubation time were finalized in the proposed method. 
The variation in flow rate and column oven temperature had not influenced significantly the 
area response and results. Helium was preferred as carrier gas over nitrogen to obtain a 
stable and consistent baseline. Since, ECH content in SVH sample was less than the 
detection limit (<0.09 µg/mL), SVH sample spiked with ECH at 1.5 µg/g level was used in 
all the developmental and validation studies. Typical retention time of ECH was 10 min. 
The retention time of ECH peak in spiked sample preparation was found to be consistent 
with standard in all the studies. 
Method validation  
Specificity  
To establish the specificity of the method, SVH sample and ECH spiked SVH sample 
preparations were subjected to hyphenated HS-GC-MS in addition to HS-GC-FI detection. 
No interference was found during the FID at the retention of ECH as illustrated in Fig. 3. 
The identity and specificity of ECH peak was further demonstrated through GC-MS. The 
total ion chromatogram (TIC) and mass spectrum of ECH and SVH spiked with ECH are 
presented in Fig. 3. The mass spectrum of ECH showed a parent peak at m/z 92 
corresponding to the molecular formula C3H5ClO. Also, it contain peaks corresponding to 
major fragments at m/z values 57 (base peak) and 49. The mass fragments, including 
base peak of ECH standard and SVH sample spiked with ECH were found comparable 
with National Institute of Standards Technology (NIST) mass spectral library for ECH. 
From the GC-MS and FID data, it could be concluded that the proposed method is specific 
for ECH determination. 
Repeatability 
ECH standard solution (0.75 µg/mL) was injected in six replicates. The RSD (n=6) value 
obtained for the area response and retention time of ECH was 3.0% and 0.03%, 
respectively.  
Linearity 
The linearity was evaluated by measuring area response for ECH over the range of 0.30 to 
10 µg/mL relative to sample concentration (500 mg/mL). Nine concentrations (n=9) were 
prepared across the range and injected each in triplicate. The mean (n=3) area calculated 
was plotted against the concentration. The coefficient of determination (r²) obtained for 
ECH was 0.999. The slope of regression line and y-intercept was 1232 and -87.6, 
respectively (Tab. 1.).  
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Fig. 3.   Overlaid chromatograms of GC-FID and GC-MS of (A) Blank, (B) SVH sample 
preparation, (C) ECH standard preparation and (D) SVH sample spiked with 
ECH; Mass spectrum of (E) ECH standard preparation and (F) SVH sample 
spiked with ECH.   Determination of Residual Epichlorohydrin in Sevelamer Hydrochloride by Static Headspace …  841 
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Tab. 1.   Method validation data for ECH impurity 
Results  Validation parameter 
ECH 
        
Detection limit (µg/mL)  0.09       
Quantitation limit (µg/mL)  0.30       
Precision at QL (n=6, % 
R.S.D) 7.2 
   
        
Linearity        
Calibration range (µg/mL)  0.30–9.98       
Calibration Points  9       
Slope 1232       
Intercept  −87.6      
Coefficient of determination 
(r
2) 0.999 
   
        
Accuracy        
Added (µg/mL)  0.300  0.751  1.501  1.802 
Recovered (µg/mL)  0.275  0.704  1.443  1.740 
% Recovery  91.7  93.7  96.1  96.6 
% R.S.D (n=3)  6.4  8.4  3.3  4.7 
        
 
Accuracy 
Accuracy of the method was validated through recovery experiments by spiking known 
amount of ECH at 0.30, 0.75, 1.5 and 1.8 µg/mL with SVH relative to sample concentration 
(500 mg/mL). Each preparation was analyzed in triplicate (n=3) and percent recovery was 
calculated. The recovery was found (Tab. 1.) to be between 91.7 and 96.6% with the RSD 
of 8.4% 
Detection (DL) and Quantitation (QL) Limit 
The DL and QL for ECH were determined by signal-to-noise ratio (S/N) method. The 
minimum concentration at 3:1 S/N was considered as DL and the concentration at 10:1 
S/N was established as QL. The DL and QL obtained for ECH was 0.045 and 0.15 µg/mL, 
respectively, which corresponded to 0.09 and 0.30 µg/mL, relative to sample concentration 
(500 mg/mL). A solution containing ECH was prepared around its QL concentration and 
injected in six replicates. The RSD (n=6) value obtained for the area of ECH at QL was 
7.2%. (Tab. 1.) 
Stability of Analyte Solution 
The stability of ECH in solution was studied by measuring the area response of standard 
solution (stored at 25 ± 2°C) injected over a period of 48 h. The RSD (n= 7) value obtained 
for the area response of ECH was 3.3 %. 842 K.  Karthikeyan  et al.:  
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Intermediate Precision 
The ruggedness of the method was evaluated by performing the SVH bulk drug sample 
analysis in six replicates using two different columns, different instruments and different 
analysts on different days. This study was done to prove the compliance of different 
chromatograph (i.e. Shimadzu and Perkin Elmer) and analysts. The RSD of the results 
(n = 6) obtained with Shimadzu and Perkin Elmer were 4.2 and 6.1%, respectively. The 
overall RSD (n = 12) of this study for ECH content was 7.3%. 
Robustness 
This study was performed by making small but deliberate variations in the method 
parameters. The effect of variation in carrier gas flow and column oven temperature on the 
ECH determination was studied. The results including system suitability test are presented 
in Tab. 2. Under all the variations, system suitability requirements (%RSD and S/N) were 
found to be well within the specified acceptance criteria. 
Tab. 2.  Robustness 
Variation RT
a  S/N  RSD (%)  ECH (µg/mL) 
No variation  10.10  3.9  3.0  1.451 
Flow rate (+10%)    9.55  3.9  2.7  1.465 
Flow rate (−10%) 10.68  3.5  2.1  1.493 
Oven initial temperature (+10%)   9.50 4.2  0.8  1.332 
Oven initial temperature (−10%) 10.67 3.6  1.8  1.540 
RSD (%)        5.3 
a retention time of ECH 
 
Discussion 
The static HS-GC method was selected in this work because of the poor solubility of SVH 
drug substance in most of the organic and aqueous solvents. Also, the existing methods 
[10–14] involved derivatization procedures, adduct analysis, SPME fibers with thermal 
desorption, mass and electrochemical detectors for ECH determination only on clean 
sample matrices. The proposed HS-GC-FID method was validated for specificity, 
repeatability, linearity, accuracy, DL, QL, stability of analyte solution, intermediate 
precision and robustness. The HS incubation temperature and incubation time were 
identified as critical parameters and the optimum condition was finalized through extensive 
variation studies. Further, to demonstrate the robustness of the method, flow rate (± 10 %) 
and column oven initial temperature (± 10 %) were also studied and no significant variation 
in the ECH content was obtained. It is significant to note that ECH peak was well resolved 
and its specificity was proved by both HS-GC-FI and MS detection. Hence, retention time 
can be used as an identification tool for the ECH presence in SVH samples. The overall 
RSD of 7.3 % for intermediate precision demonstrated the ruggedness of the method. The 
DL, QL and recovery results indicated the accuracy and capability of the method to detect 
ECH at very low levels. The limitations and complexity associated with the reported 
methods [10–14] for drug substance analysis could be overcome by the proposed method 
as it is simple, utilizing direct HS extraction and most commonly used FI detection, without   Determination of Residual Epichlorohydrin in Sevelamer Hydrochloride by Static Headspace …  843 
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any derivatization and SPME fiber extraction. Moreover, the presently developed and 
validated method is cost-effective and simple to adopt at any pharmaceutical laboratory 
with moderate run time. 
Experimental 
Chemicals and reagents 
Spectroscopy grade dimethyl sulfoxide (DMSO), N,N-dimethyl formamide (DMF) and 
1-methyl-2-pyrrolidone (NMP) were procured from Merck (Mumbai, India). Analytical grade 
N,N-dimethyl  acetamide (DMAc) was from s.d Fine Chem. Ltd (Mumbai, India). (±) 
Epichlorohydrin (99+%) was purchased from Sigma-Aldrich (Steinheim, Germany). 
Sevelamer HCl drug substance was obtained from Shasun Chemicals and Drugs Ltd., 
(Chennai, India). 
Chromatographic conditions 
All experiments were performed on Shimadzu GC2010 Gas chromatograph equipped with 
AOC 5000 headspace sampler, flame ionization detector and GC Solution software 
(Shimadzu Corporation, Japan). A Clarus 500 Gas chromatograph having Turbomatrix 40 
HS sampler, flame ionization detector with Totalchrom software (PerkinElmer, Shelton, 
USA) was used for intermediate precision and also for method development purpose. The 
specificity studies were carried out on a Shimadzu GC system coupled with quadrupole 
mass spectrometer (QP2010) and AOC5000 HS sampler (HS-GC-MS). GC-MS was 
carried out under electron impact (EI) ionization mode at 70 eV and interface, ion-source 
temperature were kept at 220 °C and 250 °C, respectively (Shimadzu Corporation, Japan). 
A Zebron ZB-Wax GC column, 60m length X 0.53mm ID X 1 µm film thickness was used 
(Phenomenex, Torrance, USA). The GC oven temperature program utilized an initial 
temperature of 50 °C, then increased at 7 °C per min to 220 °C and was held for 3 min at 
220 °C. The injector was used in splitless mode. The temperature of injector and detector 
were kept at 150 °C and 230 °C, respectively. Helium was used as carrier gas at constant 
pressure mode (8.0 psi) equivalent to the initial flow rate of 6.0 mL/min. Injection volume of 
1.0 mL for Shimadzu and injection time of 0.10 min for PerkinElmer instrument were used. 
HS conditions of both Shimadzu and PerkinElmer were presented in Tab. 3. Since, the HS 
hardware and injection techniques are different for these two instruments; some of the 
parameters of PerkinElmer were not applicable for Shimadzu and vice versa. 
Tab. 3.   Head space analyzer conditions 
HS Parameter  Shimadzu  Perkin Elmer 
Incubation temperature  100 °C  100 °C 
Incubation time  600 s  600 s 
Transfer line temperature  n.a.  120 °C 
Pressurization time  n.a.  4.0 min 
Agitator speed  250 rpm  n.a. 
Needle temperature  110 °C  110 °C 
Pneumatic pressure  n.a.  15 psi 
n.a. … not applicable 
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Solution Preparation 
Standard stock solution was prepared by dissolving 100 mg of ECH into a 100 mL glass 
volumetric flask containing 25 mL of DMSO (diluent), diluted to volume with diluent and 1.0 
mL of this solution was diluted to 100 mL using diluent (10 µg/mL). System suitability 
solution was prepared by diluting 1.5 mL of standard stock solution into 100 mL and then, 
3.0 mL of this solution was diluted to 10 mL using diluent (0.045 µg/mL). 2.0 mL of this 
solution was placed in a HS vial and sealed. Signal-to-noise ratio (S/N) for ECH peak from 
system suitability solution was evaluated with the acceptance criteria of not less than 3.0 
(S/N). Standard solution was prepared by diluting 7.5 mL of standard stock solution into a 
100 mL glass volumetric flask containing 25 mL of diluent and diluted to volume (0.75 
µg/mL). 2.0 mL of this solution was placed in a HS vial and sealed. The relative standard 
deviation (%) for the ECH peak from six replicate injections of standard solution was 
evaluated with the acceptance criteria of not more than 5.0%. Sample preparation was 
made by placing 1000 mg of SVH sample in a HS vial containing 2.0 mL of diluent and 
sealed (500 mg/mL). 
Conclusion 
The static HS-GC-FID method described in this investigation was proved to be an ideal 
tool for the determination of ECH in SVH polymeric drug substance at lower levels (< 0.3 
µg/g) to comply with the ICH/FDA/EMEA regulatory requirement. Method validation data 
demonstrated that the developed method is sensitive as well as accurate for the estimation 
of ECH and robust to minor variations in the chromatographic parameters. The identity of 
ECH and specificity of the method were well established by both HS-GC-FID and HS-GC-
MS detection. Hence, the proposed HS-GC-FID method can be employed conveniently in 
the pharmaceutical laboratory for the routine quality control of ECH in SVH drug 
substance. 
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